Nifty Midcap 150 in Red Today; Ajanta Pharma and Bharti Hexacom Stand Out with Gains

Authored By Ankur Chandra | Published at: Jun 12, 2025 12:59 PM IST

Open Free Demat Account

Mumbai, June 12, 2025 – The Nifty Midcap 150 index dipped by 0.60%, losing 131.75 points to reach 21,714.30 as of 11:44 a.m., despite some pockets of strength in individual stocks. Market breadth within the index remained subdued, with 102 stocks in the red, 48 in the green, and just 1 stock unchanged.

Index Overview

Metric	12-Jun-2025	11-Jun-2025	Change	% Change
Last Price	21,748.65	21,846.05	-97.40	-0.45%
Opening	21,868.60	—	—	—
Intraday High	21,870.00	—	—	—
Intraday Low	21,739.60	—	—	—
52-Week High	22,515.40	—	-3.41% from high
52-Week Low	17,269.50	—	+25.94% from low
1-Month Return	—	—	+7.45%
1-Year Return	—	—	+8.58%

Top Gainers in the Index

Stock	Price (₹)	Change (₹)	% Change	1M Return	1Y Return
Ajanta Pharma	2,729.50	+82.70	+3.12%	+6.63%	+11.00%
Bharti Hexacom	1,840.30	+38.60	+2.14%	+2.47%	+67.20%
Max Healthcare	1,210.50	+23.40	+1.97%	+2.35%	+47.93%
Oil India Ltd	473.95	+8.65	+1.86%	+11.73%	-28.26%
Mankind Pharma	2,423.00	+44.20	+1.86%	-4.85%	+9.77%

Market Sentiment and Trends

Even if Ajanta Pharma and Bharti Hexacom did better than the rest of the market, midcap sentiment stayed cautious because the market was consolidating. Pharmaceuticals, hospitals, and telecom stocks were strong compared to the rest of the market, which was down.

The index is near to its recent high, and investors are keeping an eye out for signals of a long-term breakout or correction as volatility continues. The index has been doing well over the past 30 and 365 days.

About Nifty Midcap 150

The Nifty Midcap 150 index represents the performance of mid-sized companies ranked 101–250 on the Nifty 500 universe. It offers diversified exposure across sectors, making it a key benchmark for India’s midcap market performance.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Markets